Coinciding with U.S. and China relations continuing to deflate, and with no premeditated intention, my discussion with President and CEO of Kintara Therapeutics, Robert E. Hoffman, and CSO (and a co-founder) Dennis Brown, focused quite a bit on the role of China-based CDMOs for Western-based drug developers. My assumed role in the discussion was as antagonist, […]

Unlike many cities, Lake Nona has a specific birthday. It began in 1996 in Orlando, FL, when the owner of Tavistock Group, Joe Lewis, bought roughly 4,000 acres with one goal: to create a community that inspires human potential and encourages health and wellness. Today, Lake Nona is a 17-square-mile, 11,000-acre community with more than […]

Convergent Therapeutics, a biotechnology company developing radiopharmaceuticals for cancer, said Wednesday that it has raised $90 million in a Series A financing led by venture investors OrbiMed and RA Capital Management. The funding will help Convergent advance is pipeline of “radioantibodies,” including its lead experimental treatment for prostate cancer.